Practicing clinicians have traditionally played a central role in research, advancing breakthrough treatments for innumerable diseases, from smallpox and cholera to heart disease and cancer. While their insights remain important as ever, recent years have seen the role of the physician-scientist become greatly diminished.

Drs. Roscoe O. Brady and Charles Robert Scriver are the recipients of the 2010 Pollin Prize in recognition of their discovery of the molecular and biochemical basis of genetic inborn errors of metabolism and for applying these findings to the development of practical interventions that have improved the lives and health of countless children and infants.

In recognition of its environmentally sustainable design, the newly opened Vivian and Seymour Milstein Family Heart Center at NewYork-Presbyterian Hospital/Columbia University Medical Center has received LEED (Leadership in Energy & Environmental Design) Gold designation from the U.S. Green Building Council.

International experts in type 2 diabetes will gather in Rome on September 27-28 to discuss how metabolic surgery may open new treatment opportunities for the disorder, which is on the rise worldwide.

A sound and restful sleep is fundamental to our health and well-being. Yet for millions of Americans, sleep is regularly interrupted or insufficient. To address the needs of this population, NewYork-Presbyterian Hospital/Weill Cornell Medical Center has established a new Center for Sleep Medicine (http://weill.cornell.edu/sleepcenter/) one of the largest academic medical programs of its kind in the country dedicated to providing comprehensive diagnosis and treatment.

Injecting a gene into patients with advanced heart failure may substantially improve clinical outcomes, according to phase II results of the multicenter CUPID (Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease) trial presented today at the 2010 American Heart Association Scientific Sessions in Chicago.

A novel genomic blood test can be developed to detect or predict multi-organ dysfunction after mechanical circulatory-support-device implantation in heart failure patients, a new study has found. The preliminary feasibility study was conducted at NewYork-Presbyterian Hospital/Columbia University Medical Center. Results were presented today at the 2010 American Heart Association Scientific Sessions in Chicago.

NewYork-Presbyterian Morgan Stanley Children's Hospital is the only medical center in the United States to offer minimally invasive liver donation for pediatric transplantation. Surgeons use a laparoscopic technique to remove a section of liver from a living donor for implantation in a pediatric patient — typically a parent donating to their child. The innovative approach promises dramatically improved recovery for the donor.